R1 RCM to be acquired by TowerBrook and CD&R for $14.30/share in cash
Under the terms of the agreement, TowerBrook, which has a 36% stake in R1 RCM, and CD&R will acquire all the outstanding ...
Morningstar1mon
R1 Wins ‘Best in KLAS’ Across Multiple RCM Categories for 2025
R1’s accolades include awards in Ambulatory RCM Services (EHR-Agnostic), Extended Business Office: Small (<200 beds), and Government Reimbursement Services. This achievement marks the fifth ...